Display options
Cite
Shoffner JM, Lott MT, Voljavec AS, et al. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci U S A. 1989;86(20):7952-6doi: 10.1073/pnas.86.20.7952.
Shoffner, J. M., Lott, M. T., Voljavec, A. S., Soueidan, S. A., Costigan, D. A., & Wallace, D. C. (1989). Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proceedings of the National Academy of Sciences of the United States of America, 86(20), 7952-6. https://doi.org/10.1073/pnas.86.20.7952
Shoffner, J M, et al. "Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy." Proceedings of the National Academy of Sciences of the United States of America vol. 86,20 (1989): 7952-6. doi: https://doi.org/10.1073/pnas.86.20.7952
Shoffner JM, Lott MT, Voljavec AS, Soueidan SA, Costigan DA, Wallace DC. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7952-6. doi: 10.1073/pnas.86.20.7952. PMID: 2554297; PMCID: PMC298190.
Copy Download .nbib Format: NLM
Share it on
Full text links
HighWire Free PMC Article

Proc Natl Acad Sci U S A. 1989 Oct;86(20):7952-6. doi: 10.1073/pnas.86.20.7952.

Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.

Proceedings of the National Academy of Sciences of the United States of America

J M Shoffner, M T Lott, A S Voljavec, S A Soueidan, D A Costigan, D C Wallace

Affiliations

  1. Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322.

PMID: 2554297 PMCID: PMC298190 DOI: 10.1073/pnas.86.20.7952
Free PMC Article

Abstract

The muscle mitochondria of a patient with Kearns-Sayre/chronic external ophthalmoplegia plus syndrome were found to be completely deficient in respiratory complex I activity and partially deficient in complex IV and V activities. Treatment of the patient with coenzyme Q10 and succinate resulted in clinical improvement of respiratory function, consistent with the respiratory deficiencies. Restriction enzyme analysis of the muscle mtDNA revealed a 4.9-kilobase deletion in 50% of the mtDNA molecules. Polymerase chain reaction analysis demonstrated that the deletion was present in the patient's muscle but not in her lymphocytes or platelets. Furthermore, the deletion was not present in the muscle or platelets of two sisters. Hence, the mutation probably occurred in the patient's somatic cells. Direct sequencing of polymerase chain reaction-amplified DNA revealed a 4977-base-pair deletion removing four genes for subunits of complex I, one gene for complex IV, two genes for complex V, and five genes for tRNAs, which paralleled the respiratory enzymes affected in the disease. A 13-base-pair direct repeat was observed upstream from both breakpoints. Relative to the direction of heavy-strand replication, the first repeat was retained and the second repeat was deleted, suggesting a slip-replication mechanism. Sequence analysis of the human mtDNA revealed many direct repeats of 10 base pairs or greater, indicating that this mechanism could account for other reported deletions. We postulate that the prevalence of direct repeats in the mtDNA is a consequence of the guanine-cytosine bias of the heavy and light strands.

Similar articles

Show all 9 similar articles

Cited by

References

  1. Anal Biochem. 1984 Feb;137(1):266-7 - PubMed
  2. Nucleic Acids Res. 1984 Jan 11;12(1 Pt 2):581-99 - PubMed
  3. Biochem J. 1984 Sep 1;222(2):463-6 - PubMed
  4. Neurology. 1985 Mar;35(3):372-7 - PubMed
  5. J Biol Chem. 1985 Aug 15;260(17):9759-74 - PubMed
  6. Science. 1985 Dec 20;230(4732):1350-4 - PubMed
  7. Neurology. 1986 Jan;36(1):45-53 - PubMed
  8. J Neurol. 1987 Jan;234(1):62-3 - PubMed
  9. J Neurol Neurosurg Psychiatry. 1987 Nov;50(11):1475-81 - PubMed
  10. Nature. 1988 Feb 25;331(6158):717-9 - PubMed
  11. Lancet. 1988 Apr 16;1(8590):885 - PubMed
  12. Mol Biol Evol. 1987 Jan;4(1):46-55 - PubMed
  13. Neurology. 1988 Jun;38(6):892-9 - PubMed
  14. Lancet. 1988 Jun 25;1(8600):1462 - PubMed
  15. Biochem Biophys Res Commun. 1988 Aug 15;154(3):1240-7 - PubMed
  16. Lancet. 1988 Sep 3;2(8610):567-8 - PubMed
  17. Neurology. 1988 Sep;38(9):1339-46 - PubMed
  18. Cell. 1988 Nov 18;55(4):601-10 - PubMed
  19. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9436-40 - PubMed
  20. Lancet. 1989 Feb 18;1(8634):393-4 - PubMed
  21. Lancet. 1989 Apr 22;1(8643):902-3 - PubMed
  22. Science. 1989 Apr 21;244(4902):346-9 - PubMed
  23. Somatic Cell Genet. 1980 Jul;6(4):543-554 - PubMed
  24. Nature. 1981 Apr 9;290(5806):457-65 - PubMed
  25. Cell. 1981 Oct;26(2 Pt 2):167-80 - PubMed
  26. Cell. 1982 Apr;28(4):693-705 - PubMed
  27. J Mol Biol. 1982 Apr 25;156(4):683-717 - PubMed
  28. Anal Biochem. 1983 Jul 1;132(1):6-13 - PubMed
  29. J Theor Biol. 1984 May 7;108(1):111-22 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources